Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS

Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes

(2013) Aristoteles Giagounidis et al.   ANNALS OF HEMATOLOGY

Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc

(2013) A. Stoddart et al.   BLOOD

Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production

(2013) M. Velegraki et al.   HAEMATOLOGICA

Overview of Myelodysplastic Syndromes

(2012) Photis Beris et al.   SEMINARS IN HEMATOLOGY

Molecular Pathophysiology of Myelodysplastic Syndromes

(2011) R. Coleman Lindsley et al.   Annual Review of Pathology-Mechanisms of Disease

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

(2011) E. Campo et al.   BLOOD

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome

(2011) M. S. Kumar et al.   BLOOD

Chronic Exposure to a TLR Ligand Injures Hematopoietic Stem Cells

(2011) B. L. Esplin et al.   JOURNAL OF IMMUNOLOGY

Classification and Prognostic Evaluation of Myelodysplastic Syndromes

(2011) Mario Cazzola et al.   SEMINARS IN ONCOLOGY

Rho-mDia1 pathway is required for adhesion, migration, and T-cell stimulation in dendritic cells

(2010) H. Tanizaki et al.   BLOOD

Innate Immune Signaling in the Myelodysplastic Syndromes

(2010) Daniel T. Starczynowski et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

How I treat patients with myelodysplastic syndromes

(2009) R. M. Stone   BLOOD

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome

(2009) M. Cazzola   HAEMATOLOGICA

The mDial Formin Is Required for Neutrophil Polarization, Migration, and Activation of the LARG/RhoA/ROCK Signaling Axis during Chemotaxis

(2009) Y. Shi et al.   JOURNAL OF IMMUNOLOGY

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer

(2009) B L Ebert   LEUKEMIA

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndrome

(2009) Jillian L Barlow et al.   NATURE MEDICINE

Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

(2009) Daniel T Starczynowski et al.   NATURE MEDICINE

5q– myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics

(2009) K M Eisenmann et al.   ONCOGENE

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

(2008) Benjamin L. Ebert et al.   NATURE